DeepScan

Evidence-Based cfDNA Diagnostics for Dogs

DeepScan's cfDNA diagnostics help veterinarians detect and monitor disease earlier, supporting better decisions and longer pet healthspan.

Trusted by Leaders in Veterinary Research and Clinical Practice

Pieni Eläinsairaala
Sploot Veterinary Care
LiVet
SoVet
Porvoon

“Our profession has been searching for an ease of use, affordable and accurate blood test that can serve as an aid in cancer diagnosis and a tool for treatment monitoring. CFD has the potential to fundamentally improve how cancer treatments are planned in the future, providing better outcomes for our patients and clarity for their families.”

Zachary M. Wright

Zachary M. Wright

Medical Director,
VCA Dallas Animal Specialty Hospital

What is the CFD® Biomarker?

The CFD® biomarker measures circulating cell-free DNA (cfDNA) levels in blood, which correlates with cell destruction in the body. This powerful clinical insight helps veterinarians assess disease severity, detect hidden conditions, and monitor treatment efficacy across acute emergencies and chronic disease management.

The CFD® Biomarker

Built on a Foundation of Unparalleled Data and Validation

Latest Manuscript

Circulating cell-free DNA as a canine health biomarker

Veterinary Science · 2025

Download Manuscript

Pilot Studies

CFD vs cPLI in Acute Pancreatitis

CFD Monitoring for Phenobarbital-Induced Hepatotoxicity

CFD vs CRP in Neoplasia

CFD in Splenic Disease

CFD Monitoring in Lymphoma Remission

See All Pilot Studies

Conference Abstracts

Presented at ESVONC 2025

1

Minimising Variability of Preanalytical Factors is Key to Successful cfDNA Testing

2

Circulating Cell Free DNA (cfDNA) Reveals Hidden Illnesses in Dogs

3

Cell-Free DNA as a Biomarker for ECT and IL-12 GET Treatment Response in Dogs

View All Abstracts

Led by Experts in Veterinary Oncology and Data Science

Our team combines deep expertise in veterinary oncology, data science, and molecular diagnostics to deliver evidence-based cfDNA solutions that support veterinarians and improve outcomes for dogs.

Katja Kivinen, PhD

Katja Kivinen, PhD

Chief Scientific Officer

Gugan Eswaran, PhD

Gugan Eswaran, PhD

Head of Research and Development

Milja Tikkanen

Milja Tikkanen

Head of Laboratory

Emmi Hurskainen

Emmi Hurskainen

Laboratory Manager

Ready to integrate the CFD® biomarker into your practice?